mRNA |
DMOG |
GDSC1000 |
pan-cancer |
AAC |
-0.025 |
0.4 |
mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
-0.035 |
0.5 |
mRNA |
pifithrin-alpha |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.5 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.5 |
mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.5 |
mRNA |
MS-275 |
gCSI |
pan-cancer |
AAC |
-0.038 |
0.5 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.5 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.5 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.5 |